Amneal gets FDA approval for memantine/donepezil extended-release capsules
Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...
Pharm Exec5h
FDA Approves Two Generics from Amneal Pharmaceuticals for Alzheimer and Oncology, with Tentative Approval for Gastrointestinal Disease
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in patients with Alzheimer disease, with Everolimus receiving approval for ...
Medscape16d
Donepezil Shows Promise in TBI Recovery
Donepezil was associated with improved verbal memory and processing speed compared to placebo in patients with TBI and severe ...